Alcon Recalls GenTeal Tears Eye Gel Over Sterility Concerns

Alcon Research LLC recalled one specific lot of GenTeal Tears Lubricant Eye Gel on May 6, 2026. The product is a sterile, 10g tube of lubricating eye gel with National Drug Code (NDC) 0065-8064-01. The company initiated the recall following an FDA inspection. Agency inspectors identified observations that could affect product quality, leading to a lack of assurance of sterility.

Patients Should Stop Using Affected Product Immediately

If you have this exact product in your home, do not use it. You should stop application right away, even if you have not noticed any problems. Check the NDC number on the tube to confirm it matches 0065-8064-01. Do not return the product to a pharmacy or store. Instead, dispose of it in your household trash. For a refund or to ask questions, contact Alcon directly using their consumer relations line at 1-800-757-9195.

Consumers using the gel for dry eye relief should talk to their doctor, pharmacist, or eye care professional. They can recommend an alternative lubricating eye drop or gel that is safe to use. It is important to continue managing eye health under professional guidance.

Why Sterility in Ophthalmic Products Matters

Any product labeled “sterile” and designed for use in the eyes must be free of harmful microorganisms. The eye is a particularly vulnerable organ. Introducing bacteria or fungi through a contaminated gel can lead to serious infections. Potential conditions include bacterial keratitis, an infection of the cornea. This can cause pain, redness, blurred vision, light sensitivity, and in severe cases, permanent vision damage or blindness.

The recall is classified by the FDA as a Class II recall. This means the use of the product may cause temporary or medically reversible health problems. The probability of serious adverse health consequences is considered remote. However, the risk cannot be ruled out, prompting the voluntary market withdrawal.

Connecting Eye Health to Hearing and Tinnitus Research

This recall highlights a broader principle in patient care: systemic health and sensory systems are often interconnected. Research institutions like the Massachusetts Eye and Ear Infirmary frequently study both auditory and visual pathways. Compromised health in one sensory system can sometimes indicate or influence another.

For patients managing tinnitus or hearing health, maintaining overall wellness is a common recommendation. An eye infection from a contaminated product could require treatments, like certain antibiotics, that have ototoxic potential. While rare, this represents an indirect risk. It underscores the need for strict manufacturing quality controls for all medications, especially those used in sensitive sensory organs.

The action by Alcon and the FDA is a standard regulatory procedure designed to protect public health. Patients should view this as a cautionary step, not a cause for alarm. Always verify the lot and NDC numbers of medical products and report any adverse reactions to your doctor and the FDA MedWatch program.

Source:
FDA Safety Alerts